Sunday, April 2, 2023 | Back issues
Courthouse News Service Courthouse News Service

Big Pharma

Allergan faces a federal class action alleging that the pharmaceutical giant's two retirement plans wasted assets by buying inflated Allergan stock.

NEWARK, N.J. – Allergan, the pharmaceutical giant previously known as Actavis, faces a federal class action alleging that two retirement plans wasted assets by buying inflated Allergan stock.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading...